Publicacions en col·laboració amb investigadors/es de Clínica Universitaria de Navarra (65)

2024

  1. Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy

    Radiotherapy and Oncology, Vol. 198

  2. First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies

    Clinical Genitourinary Cancer

2022

  1. Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

    Nature medicine, Vol. 28, Núm. 4, pp. 752-765

2021

  1. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis

    Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1934-1941

2019

  1. A novel concept to include uncertainties in the evaluation of stereotactic body radiation therapy after 4D dose accumulation using deformable image registration

    Medical Physics, Vol. 46, Núm. 10, pp. 4346-4355

  2. Immune mechanisms mediating abscopal effects in radioimmunotherapy

    Pharmacology and Therapeutics, Vol. 196, pp. 195-203

  3. Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study

    Radiotherapy and Oncology, Vol. 135, pp. 91-99

2018

  1. Rescuing Spanish Radiation Therapy: The Role of Leadership and Opportunity

    International Journal of Radiation Oncology Biology Physics

2017

  1. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

2016

  1. Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes

    Brachytherapy, Vol. 15, Núm. 2, pp. 127-135

  2. GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases

    Annals of Oncology, Vol. 27, pp. vi383

2015

  1. Pneumomediastinum as a complication of SABR for lung metastases

    Radiation Oncology, Vol. 10, Núm. 1

  2. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome

    Radiotherapy and Oncology, Vol. 116, Núm. 2, pp. 316-322

  3. The Role of Intensity-Modulated Radiotherapy to Optimize Outcomes in Locally Advanced Rectal Cancer

    Current Colorectal Cancer Reports, Vol. 11, Núm. 6, pp. 345-351

2013

  1. Intraoperative EBRT and resection for renal cell carcinoma: Twenty-year outcomes

    Strahlentherapie und Onkologie, Vol. 189, Núm. 2, pp. 129-136

2012

  1. Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer

    Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088

  2. External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: Preliminary data on clinical outcome

    International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 3

  3. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

  4. Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review

    Radiation Oncology, Vol. 7, Núm. 1

2011

  1. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: Volumetric analysis of extent of resection in single-center experience

    Journal of Neuro-Oncology, Vol. 102, Núm. 1, pp. 105-113